Literature DB >> 10639331

Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene.

D P Thomas1, A Sunters, A Gentry, A E Grigoriadis.   

Abstract

We have investigated the role of c-Fos in chondrocyte differentiation in vitro using both constitutive and inducible overexpression approaches in ATDC5 chondrogenic cells, which undergo a well-defined sequence of differentiation from chondroprogenitors to fully differentiated hypertrophic chondrocytes. Initially, we constitutively overexpressed exogenous c-fos in ATDC5 cells. Several stable clones expressing high levels of exogenous c-fos were isolated and those also expressing the cartilage marker type II collagen showed a marked decrease in cartilage nodule formation. To investigate further whether c-Fos directly regulates cartilage differentiation independently of potential clonal variation, we generated additional clones in which exogenous c-fos expression was tightly controlled by a tetracycline-regulatable promoter. Two clones, DT7.1 and DT12.4 were capable of nodule formation in the absence of c-fos. However, upon induction of exogenous c-fos, differentiation was markedly reduced in DT7.1 cells and was virtually abolished in clone DT12.4. Pulse experiments indicated that induction of c-fos only at early stages of proliferation/differentiation inhibited nodule formation, and limiting dilution studies suggested that overexpression of c-fos decreased the frequency of chondroprogenitor cells within the clonal population. Interestingly, rates of proliferation and apoptosis were unaffected by c-fos overexpression under standard conditions, suggesting that these processes do not contribute to the observed inhibition of differentiation. Finally, gene expression analyses demonstrated that the expression of the cartilage markers type II collagen and PTH/PTHrP receptor were down-regulated in the presence of exogenous c-Fos and correlated well with the differentiation status. Moreover, induction of c-fos resulted in the concomitant increase in the expression of fra-1 and c-jun, further highlighting the importance of AP-1 transcription factors in chondrocyte differentiation. These data demonstrate that c-fos overexpression directly inhibits chondrocyte differentiation in vitro, and therefore these cell lines provide very useful tools for identifying novel c-Fos-responsive genes that regulate the differentiation and activity of chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639331     DOI: 10.1242/jcs.113.3.439

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  19 in total

1.  Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.

Authors:  Blanca Scheijen; Marieke Bronk; Tiffany van der Meer; René Bernards
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Regulation of the transcriptional activation of CTRP3 in chondrocytes by c-Jun.

Authors:  Mi-Jin Kim; Eun-Ju Park; Wan Lee; Jung-Eun Kim; Seung-Yoon Park
Journal:  Mol Cell Biochem       Date:  2012-05-30       Impact factor: 3.396

3.  Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3.

Authors:  Soo Hwa Jang; Jun Kyu Byun; Won-Il Jeon; Seon Young Choi; Jin Park; Bo Hyung Lee; Ji Eun Yang; Jin Bong Park; Scott M O'Grady; Dae-Yong Kim; Pan Dong Ryu; Sang-Woo Joo; So Yeong Lee
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

Review 4.  Functions of AP1 (Fos/Jun) in bone development.

Authors:  E F Wagner
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

5.  A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E.

Authors:  Philipp G Maass; Jutta Wirth; Atakan Aydin; Andreas Rump; Sigmar Stricker; Sigrid Tinschert; Miguel Otero; Kaneyuki Tsuchimochi; Mary B Goldring; Friedrich C Luft; Sylvia Bähring
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

6.  Using pre-existing microarray datasets to increase experimental power: application to insulin resistance.

Authors:  Bernie J Daigle; Alicia Deng; Tracey McLaughlin; Samuel W Cushman; Margaret C Cam; Gerald Reaven; Philip S Tsao; Russ B Altman
Journal:  PLoS Comput Biol       Date:  2010-03-26       Impact factor: 4.475

7.  Retinoic acid and the transcription factor MafB act together and differentially to regulate aggrecan and matrix metalloproteinase gene expression in neonatal chondrocytes.

Authors:  Yao Zhang; A Catharine Ross
Journal:  J Cell Biochem       Date:  2013-02       Impact factor: 4.429

8.  Unlike ghrelin, obestatin does not exert any relevant activity in chondrocytes.

Authors:  Rocio Lago; Rodolfo Gomez; Carlos Dieguez; Juan J Gomez-Reino; Francisca Lago; Oreste Gualillo
Journal:  Ann Rheum Dis       Date:  2007-10       Impact factor: 19.103

9.  Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo.

Authors:  Qiping Zheng; Bettina Keller; Guang Zhou; Dobrawa Napierala; Yuqing Chen; Bernhard Zabel; Andrew E Parker; Brendan Lee
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

Review 10.  Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism.

Authors:  M B Goldring; M Otero; K Tsuchimochi; K Ijiri; Y Li
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.